to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
A healthcare VC predicts that more DNA sequencing and the shift from patients to healthcare consumers, among other things, will rule the future of healthcare innovation.
Last month, the Kauffman Foundation announced a grant aimed at curating data on young companies from cities around the world. Our partner in this endeavor is Startup Genome; a free and open platform for collecting, curating and analyzing data about the startups, entrepreneurs, investors and community enablers in a local startup community.
Lately, there's been a lot of talk about these people we call millennials. Namely, the current generation, Generation Y, those "entitled, narcissists who still live with their parents", according to Keith Wagstaff. From complimentary to derisive, countless writers have deemed it their duty to predict exactly what this generation will add or (as most reports warn) detract from our current society. But the truth is, nothing has been said about the "Me, me, me generation" that hasn't been said about every generation before them.
A strong intellectual property portfolio is key to your healthcare startup. Read how to go about getting a patent for your innovative medical device.
Non-dilutive funding offers startups a lot of advantages, but some entrepreneurs get caught up chasing too many grants. Read more about choosing which funding sources to pursue.
What would you do if you were promised $24 million in funding – but the venture firm changed its mind?
In the past, Dr. Amy Baxter was able to practice emergency medicine while developing a new medical device that deadens the pain from injections. But working on her startup during the day and picking up night shifts at the hospital could only go on for so long.
I recently returned from participating in the 2nd Annual Rome Forum of the Harambe Entrepreneurial Alliance, hosted by the Vatican's Pontifical Council for Justice and Peace.
Should the U.S. Food and Drug Administration protect the public or drive innovation? One industry leader gives us his take on the future of the FDA.
We recently hosted the inaugural class for the Ice House Entrepreneurship Education Program. The program coincidentally started just as the debt ceiling debacle was playing out in Washington. There was a shared moment of awareness that maybe those we feel should be making the economic ecosystem a better place for entrepreneurs were in fact incapable of doing so, and even doing things that were self-destructive; a reality driven home by the subsequent credit downgrade by S&P.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.